Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00559338 · ClinicalTrials.gov registry record · Phase 4
Impact of Nesiritide Infusion for Decompensated Heart Failure in the Emergency Department
A Phase 4 study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 104
- Enrollment target
NCT00559338 is a Phase 4 study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 104 participants.
The verdict
NCT00559338, a Phase 4 study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 104 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if an 8hr infusion of nesiritide in the emergency department in the Acutely decompensated heart failure patients will decrease 30 day recidivism.
Interventions
- DRUG placebo
- DRUG recombinant B-type, natriuretic peptide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2003-12 |
| Est. Completion | 2005-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00559338
The ClinicalTrials.gov registry entry for NCT00559338 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 104 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00559338 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00559338 about?
NCT00559338 is a clinical study titled "Impact of Nesiritide Infusion for Decompensated Heart Failure in the Emergency Department". The purpose of this study is to determine if an 8hr infusion of nesiritide in the emergency department in the Acutely decompensated heart failure patients will decrease 30 day recidivism.
What is the current status of trial NCT00559338?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 104 participants. The study started on 2003-12. Estimated completion is 2005-04.
What interventions are being tested in trial NCT00559338?
The interventions under investigation include: placebo (DRUG), recombinant B-type, natriuretic peptide (DRUG).
Who is sponsoring clinical trial NCT00559338?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.